First, we evaluated the effects of JQ1 on peritoneal fibrosis outcomes by stimulating MeT-5A cells with TGF-β1 and IL-1β for 24 h, a combination previously described to induce MMT [4]. This evidence concerns the gene IL1B and Peritoneal Fibrosis.